GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3983-3988

  Giavoli, Claudia ^a,b   Profka, Eriselda ^a,b   Verrua, Elisa ^a,b   Ronchi, Cristina L ^c   Ferrante, Emanuele ^a,b   Bergamaschi, Silvia ^a,b   Sala, Elisa ^a,b   Malchiodi, Elena ^a,b   Lania, Andrea G ^a   Arosio, Maura ^a,d   Ambrosi, Bruno ^a   Spada, Anna ^a,b   Beck Peccoz, Paolo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; MALE; METABOLIC PARAMETERS; NONFUNCTIONING PITUITARY ADENOMA; OPEN STUDY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONS ON LIFE SATISFACTION HYPOPITUITARISM Z SCORE; SCORING SYSTEM; WAIST CIRCUMFERENCE;

ACROMEGALY; ADULT; BLOOD GLUCOSE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84868609968     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2477     Document Type: Article

References (22)

1. Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS 2011 The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Clin Endocrinol (Oxf) 75:220-225
2. Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavò S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M 2012 Predictors of morbidity and mortality in acromegaly, an Italian survey. Eur J Endocrinol 167:189-198
3. Ronchi CL, Giavoli C, Ferrante E, Verrua E, Bergamaschi S, Ferrari DI, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P 2009 Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments. Eur J Endocrinol 161:37-42
4. de Boer H, Block GJ, Van der Veen VA 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
5. Salomon F, Cuneo RC, Hesp R, Sönksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adult with growth hormone deficiency. N Engl J Med 321:1797-1803 (Pubitemid 20015573)
6. Drake WM, Coyte D, Camacho-Hübner C, Jivanji NM, Kaltsas O, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83:3913-3919 (Pubitemid 28513572)
7. Molitch ME, Clemmons DR, Molozowski S, Merriam GR, Vance ML 2011 Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 96:1587-1609
8. Lin E, Wexler TL, Nachtigall L, Tritos N, Sweaingen B, Hemphill L, Loeffler J, Biller BM, Klibanski A, Miller KK 8 February 2012 Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf) 10.1111/j.1365-2265.2012.04361.x
9. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster C, and the KIMS International Board on behalf of the KIMS Study Group 2002 Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Eur J Endocrinol 146:67-74
10. Norrman LL, Johansson G, Sunnerhagen KS, Svensson J 2008 Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly. J Clin Endocrinol Metab 93:2531-2538 (Pubitemid 352013498)
11. van der Klaauw AA, Bax JJ, Roelfsema F, Stokkel MP, Bleeker GB, Biermasz NR, Smit JW, Romijn JA, Pereira AM 2009 Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 12:339-346
12. Miller K, Wexler T, Fateli P, Gunnel L, Graham GJ, Beauregard C, Hemphill L, Nachtigal L, Loeffler J, Swearingen B, Biller BM, Klibanski A 2010 Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab 95:567-577
13. Valassi E, Brick DJ, Johnson JC, Biller BM, Klibanski A, Miller KK 2012 Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiencywhohave a history of acromegaly versus other disorders. Endocr Pract 18:209-218
14. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
15. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G 2005 The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257-264 (Pubitemid 41174451)
16. van der Klaaw AA, Pereira AM, van Thiel SW, Smit JW, Corssmit EP, Biermasz NR, Frohlich M, Iranmanesh A, Veldhuis JD, Roelfsema F, Romijn JA 2006 GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion. Eur J Endocrinol 154:851-858 (Pubitemid 43997724)
17. Conceição FL, Fisker S, Andersen M, Kaal A, Jørgensen JO, Vaisman M, Christiansen JS 2003 Evaluation of growth hormone stimulation tests in cured acromegalic patients. Growth Horm IGF Res 13:347-352
18. Giavoli C, Libé R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A, Beck-Peccoz P 2004 Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab 89:5397-5401 (Pubitemid 39518415)
19. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M, Beck-Peccoz P 2002 Recombinant human GH therapy and thyroid function in a large group of adult GH-deficient patient: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 87:2042-2045 (Pubitemid 34521487)
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Tracher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
21. Friedwald WT, Levy RI, Friedrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
22. Blum WF, Shavrikova EP, Edwards DJ, Rosilio M, Hartman ML, Marín F, Valle D, van der Lely AJ, Attanasio AF, Strasburger CJ, Henrich G, Herschbach P 2003 Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module. J Clin Endocrinol Metab 88:4158-4167 (Pubitemid 37158032)